HCM
Price:
$17.38
Market Cap:
$3.03B
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract ca...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-03-16
Stock Exchange
NASDAQ
Ticker
HCM
According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current PE Ratio is -69.52. This represents a change of -415.26% compared to the average of 22.05 of the last 4 quarters.
The mean historical PE Ratio of HUTCHMED (China) Limited over the last ten years is 155.13. The current -69.52 PE Ratio has changed -4581.30% with respect to the historical average. Over the past ten years (40 quarters), HCM's PE Ratio was at its highest in in the March 2016 quarter at 7.24K. The PE Ratio was at its lowest in in the March 2018 quarter at -419.93.
Average
155.13
Median
-72.69
Minimum
-949.52
Maximum
1.32K
Discovering the peaks and valleys of HUTCHMED (China) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.15%
Maximum Annual PE Ratio = 1.32K
Minimum Annual Increase = -600.13%
Minimum Annual PE Ratio = -949.52
Year | PE Ratio | Change |
---|---|---|
2023 | 152.68 | -600.13% |
2022 | -30.53 | -75.01% |
2021 | -122.15 | 6.34% |
2020 | -114.86 | -0.63% |
2019 | -115.59 | -43.63% |
2018 | -205.04 | -78.41% |
2017 | -949.52 | -237.07% |
2016 | 692.71 | -24.96% |
2015 | 923.18 | -30.09% |
2014 | 1.32K | 11.15% |
The current PE Ratio of HUTCHMED (China) Limited (HCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.00
5-year avg
-46.09
10-year avg
155.13
HUTCHMED (China) Limited’s PE Ratio is less than Eagle Pharmaceuticals, Inc. (5.10), less than ANI Pharmaceuticals, Inc. (43.28), less than Phibro Animal Health Corporation (324.20), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Prestige Consumer Healthcare Inc. (18.08), less than Pacira BioSciences, Inc. (10.06), less than Collegium Pharmaceutical, Inc. (12.07), less than Procaps Group S.A. (4.69), less than Silver Spike Investment Corp. (14.29), less than Alkermes plc (15.66), greater than Intra-Cellular Therapies, Inc. (-90.48), less than Ironwood Pharmaceuticals, Inc. (77.85), less than Regencell Bioscience Holdings Limited (-18.48),
Company | PE Ratio | Market cap |
---|---|---|
5.10 | $55.19M | |
43.28 | $1.27B | |
324.20 | $788.20M | |
-11.74 | $2.21B | |
18.08 | $3.68B | |
10.06 | $638.86M | |
12.07 | $1.20B | |
4.69 | $218.91M | |
14.29 | $71.22M | |
15.66 | $4.42B | |
-90.48 | $7.77B | |
77.85 | $720.42M | |
-18.48 | $87.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HUTCHMED (China) Limited's PE Ratio?
How is the PE Ratio calculated for HUTCHMED (China) Limited (HCM)?
What is the highest PE Ratio for HUTCHMED (China) Limited (HCM)?
What is the 3-year average PE Ratio for HUTCHMED (China) Limited (HCM)?
What is the 5-year average PE Ratio for HUTCHMED (China) Limited (HCM)?
How does the current PE Ratio for HUTCHMED (China) Limited (HCM) compare to its historical average?